Cognitive Difficulties Tied to Lower Return to Work After Breast Cancer
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 23, 2024 -- Return to work two years after a breast cancer diagnosis is associated with higher cognitive speed performance before and after treatment, according to a study published online Aug. 19 in JAMA Network Open.
Marie Lange, Ph.D., from Normandie Université UNICAEN in Caen, France, and colleagues examined whether cognition, assessed using objective and subjective scores, was associated with return to work two years after a breast cancer diagnosis. The analysis included 178 women with breast cancer.
The researchers found that 20.8 percent of women did not return to work at year 2. Returning to work was more likely among patients with a higher occupational class (i.e., professional) and less likely among those who had a mastectomy (24.1 versus 54.1 percent). There was an association between return to work at year 2 and lower overall cognitive impairment (1-point unit of increased odds ratio [1-pt OR], 0.32), higher working memory (1-pt OR, 2.06), higher processing speed (1-pt OR, 1.97), higher attention performance (1-pt OR, 1.63), higher perceived cognitive abilities (1-pt OR, 1.12), and lower depression (1-pt OR, 0.83). There were associations observed between return to work and higher processing speed (1-pt OR at baseline and year 1, 2.38 and 1.95, respectively), higher executive performance (1-pt ORs, 2.61 and 2.88, respectively), and lower physical fatigue (10-pt ORs, 0.81 and 0.84, respectively).
"Cognitive difficulties should be assessed before return to work to propose suitable management," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Epilepsy More Common With Frontotemporal Dementia
TUESDAY, June 10, 2025 -- Epilepsy is more common among those with frontotemporal dementia (FTD) than among people with Alzheimer disease (AD) or healthy controls, according to a...
Preoperative Blood Pressure Strategies Yield Similar Postoperative Cognitive Results
FRIDAY, June 6, 2025 -- For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies...
Odds of Advanced Cancer, Breast Cancer Death Lower in Screen-Detected Disease
THURSDAY, June 5, 2025 -- For patients aged 40 years or older, screen-detected breast cancer is associated with lower odds of advanced cancer, mastectomy, and breast...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.